Last reviewed · How we verify

NCT04990648

Buzzy® Application in Pain

Completed NA Last updated 4 August 2021
What this trial tests

NA trial testing Buzzy in Healthy in 60 participants. Completed in 15 May 2019.

Timeline
15 November 2018
Primary endpoint
15 May 2019
15 May 2019

Quick facts

Lead sponsorOkan University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment60
Start date15 November 2018
Primary completion15 May 2019
Estimated completion15 May 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Okan University

Who can join

Adults 12 Months to 12 Months, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The research was conducted as a randomized controlled experiment to investigate the effect of Buzzy® on pain level during the measles-rubella-mumps (MMR) vaccine injection in 12-month-old infants. This study was done with infants meeting the sampling criteria (buzzy group: 30, control group: 30) on November 2018-May 2019 in Istanbul Bakirkoy 9 Family Health Center.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Buzzy

Trials testing the same drug.

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other Okan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04990648.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing